WO2006106994A8 - Drug for periodontal disease comprising component extracted from aesculus hippocastanum l. - Google Patents

Drug for periodontal disease comprising component extracted from aesculus hippocastanum l. Download PDF

Info

Publication number
WO2006106994A8
WO2006106994A8 PCT/JP2006/306978 JP2006306978W WO2006106994A8 WO 2006106994 A8 WO2006106994 A8 WO 2006106994A8 JP 2006306978 W JP2006306978 W JP 2006306978W WO 2006106994 A8 WO2006106994 A8 WO 2006106994A8
Authority
WO
WIPO (PCT)
Prior art keywords
drug
periodontal disease
aesculus hippocastanum
component extracted
component
Prior art date
Application number
PCT/JP2006/306978
Other languages
French (fr)
Japanese (ja)
Other versions
WO2006106994A1 (en
Inventor
恵介 梶田
英寿 金
秀晃 北郡
Original Assignee
小林製薬株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 小林製薬株式会社 filed Critical 小林製薬株式会社
Publication of WO2006106994A1 publication Critical patent/WO2006106994A1/en
Publication of WO2006106994A8 publication Critical patent/WO2006106994A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

[PROBLEMS] To provide a novel drug for periodontal disease which has an excellent effect of inhibiting abnormal extension of a gingival epithelial tissue. [MEANS FOR SOLVING PROBLEMS] A drug for periodontal disease containing a component which is obtained by extracting Aesculus hippocastanum L. with a solvent and isolating; and a composition to be used in the oral cavity for treating oral diseases such as gingivitis and periodontitis which contains the above drug.
PCT/JP2006/306978 2005-03-31 2006-03-31 Drug for periodontal disease comprising component extracted from aesculus hippocastanum l. WO2006106994A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005103745A JP2006282562A (en) 2005-03-31 2005-03-31 Agent for periodontosis compounded with aesculus hippocastanum l. extract component
JP2005-103745 2005-03-31

Publications (2)

Publication Number Publication Date
WO2006106994A1 WO2006106994A1 (en) 2006-10-12
WO2006106994A8 true WO2006106994A8 (en) 2009-08-27

Family

ID=37073544

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2006/306978 WO2006106994A1 (en) 2005-03-31 2006-03-31 Drug for periodontal disease comprising component extracted from aesculus hippocastanum l.

Country Status (2)

Country Link
JP (1) JP2006282562A (en)
WO (1) WO2006106994A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5710111B2 (en) * 2009-07-14 2015-04-30 株式会社ロッテ Antibacterial agent consisting of lactitol and maltitol
KR20230033488A (en) * 2021-09-01 2023-03-08 주식회사 안지오랩 Composition comprising the the horse chestnut extracts

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5758613A (en) * 1980-09-26 1982-04-08 Lion Corp Composition for oral cavity application
JPS5782307A (en) * 1980-11-12 1982-05-22 Lion Corp Composition for oral purpose
DE3241017C1 (en) * 1982-11-06 1983-12-15 Blendax-Werke R. Schneider Gmbh & Co, 6500 Mainz Dental and oral care products
KR0138248B1 (en) * 1992-10-07 1998-05-15 최근선 The oral cavity hygienic compositions
JP3570482B2 (en) * 1997-12-02 2004-09-29 ライオン株式会社 Dentifrice composition and method for suppressing bitterness
FR2799369B1 (en) * 1999-10-08 2001-12-21 Oreal COMBINATION OF ESCINE AND DEXTRAN SULFATE AND THE USE THEREOF
WO2002047701A1 (en) * 2000-12-12 2002-06-20 Angiolab, Inc. Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity
EP1438059A4 (en) * 2001-10-26 2008-01-23 Angiolab Inc Composition containing horse chestnut extract for anti-angiogenic and matrix metalloproteinase inhibitory activity

Also Published As

Publication number Publication date
JP2006282562A (en) 2006-10-19
WO2006106994A1 (en) 2006-10-12

Similar Documents

Publication Publication Date Title
WO2007077259A8 (en) Synergistic active preparations comprising diphenylmethane derivatives and further skin and/or hair lightening and/or senile keratosis reducing compounds
MY149181A (en) Isoxazoline derivative and preparation process thereof
WO2006114520A3 (en) Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof
WO2008070368A3 (en) Methods and compositions for skin care
EA201001555A1 (en) ANTIOXIDATIVE INFLAMMATION MODULATORS: DERIVATIVESIC DERIVATIVES WITH AMINUM AND OTHER MODIFICATIONS OF C-17
HUP0303354A2 (en) 6-alpha, 9-alpha-difluoro-17-alpha-(2-furanylcarboxyl)oxy-11-betha-hydroxy-16-alpha-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester with anti-inflammatory effect, process for its preparation and pahrmaceutical composition containing it
ATE536859T1 (en) MACA EXTRACT AND COSMETIC COMPOSITION CONTAINING THIS EXTRACT
WO2008001325A3 (en) Herbal compositions for the treatment of diseases of the oral cavity
MX341211B (en) Synthesis of a novel nitroxide antioxidant and methods of use in cosmetic and dermatological compositions.
WO2012120290A3 (en) Cosmetic formulations
MX2009006695A (en) N-substituted-p-menthane-3-carboxamide and uses thereof.
DE502005010342D1 (en) Substituierte cyclohexylessigsäure-derivate
DK1976391T3 (en) Chewing gum composition containing aronia berries
ES2328496T3 (en) 1,4,8-TRIAZA-ESPIRO (4,5) DECAN-2-ONA SUBSTITUTED COMPOUNDS.
EP1831239B8 (en) A process for the preparation of 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylene-17 alpha-pregn-4-ene-3-one-21-carboxylic acid gamma-lactone and key-intermediates for this process
WO2007012080A3 (en) Oral care composition
EA201200892A1 (en) COMPOSITION FOR ORAL HYGIENE
WO2005018342A8 (en) Compositions and methods for the maintenance of oral health
WO2004089329A3 (en) Topical compositions comprising n-acetylamino acids or related n-acetyl compounds
MX2011013130A (en) Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics.
WO2010121213A3 (en) Antibacterial compositions
WO2005055943A3 (en) Vinorelbine derivatives
WO2006106994A8 (en) Drug for periodontal disease comprising component extracted from aesculus hippocastanum l.
BRPI0411702B8 (en) use of hyaluronic acid to prepare compositions for the treatment of thrush of the oral cavity
BRPI0411087A (en) improvements in or related to organic compounds

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06730926

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP